CPI-1189: Phase IIa

Interim results from Centaur's U.S. Phase IIa trial in 64 HIV infected patients with AIDS dementia showed

Read the full 171 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE